Back to Search
ARON POLLACK, MD
MD
Otolaryngology Physician
NPI: 1295052595IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
MD454642(PA)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
OTHER
Class of 2010
Research & Publications (20)
Comparing computed tomography localization with daily ultrasound during image-guided radiation therapy for the treatment of prostate cancer: a prospective evaluation.
PMID 17712295·J Appl Clin Med Phys·2007
4-observational
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.
PMID 16242256·Int J Radiat Oncol Biol Phys·2006
4-observational
Muscarinic receptor blockade attenuates reserpine-mediated Fos induction in the rat striatopallidal pathway.
PMID 16153612·Brain Res·2005
7-preclinical
Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats.
PMID 15700284·Synapse·2005
4-observational
Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
PMID 16264846·Nat Clin Pract Oncol·2005
3-trial
Acute neurological complications following gamma knife surgery for vestibular schwannoma. Case report.
PMID 16235688·J Neurosurg·2005
5-case
Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs.
PMID 15494560·Sci STKE·2004
6-review
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02.
PMID 15169799·J Clin Oncol·2004
8-other
Results of combined surgery by phacoemulsification and vitrectomy.
PMID 15055268·Isr Med Assoc J·2004
4-observational
Prostate cancer radiotherapy dose response: an update of the fox chase experience.
PMID 14767286·J Urol·2004
8-other
Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity.
PMID 14592813·Am J Physiol Cell Physiol·2004
7-preclinical
Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatment.
PMID 12735509·Urol Clin North Am·2003
6-review
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT.
PMID 12961097·World J Urol·2003
6-review
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy.
PMID 12909210·Int J Radiat Oncol Biol Phys·2003
4-observational
Treatment of prostate cancer with regional lymph node (N1) metastasis.
PMID 12728441·Semin Radiat Oncol·2003
6-review
Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.
PMID 12663710·J Clin Oncol·2003
3-trial
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.
PMID 12655519·Cancer·2003
8-other
Peripheral retinoschisis and exudative retinal detachment in pars planitis.
PMID 12476097·Retina·2002
5-case
Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.
PMID 12377318·Int J Radiat Oncol Biol Phys·2002
3-trial
Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer.
PMID 12231041·Urology·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 LOTHROP ST, SUITE 300
PITTSBURGH, PA 15213 - Phone
- (412) 647-2030
Quick Facts
- NPI
- 1295052595
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile